Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71205-408

5 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71205-408). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)
A scatter plot chart presenting pharmacokinetic (PK) fold changes and 90% confidence interval (CI) recommendations for venlafaxine interactions with various drugs. The chart compares Cmax and AUC values of venlafaxine relative to reference values when co-administered with drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium, with corresponding clinical recommendations.*
FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)
A pharmacokinetic interaction chart showing the effect of various interacting drugs on the Cmax and AUC of Venlafaxine Hydrochloride, extended release 37.5 mg capsules. It plots fold changes with 90% confidence intervals for drugs including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium, with recommendations on dose adjustment or clinical significance.*
FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)
A forest plot chart showing pharmacokinetic changes (Cmax and AUC) of venlafaxine in various special populations, including hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60 years, and gender. The chart displays fold changes relative to reference values with 90% confidence intervals and dosing recommendations for these populations.*
FDA Label Image

71205-408-30 (Venlafaxine Fig4)

71205-408-30 (Venlafaxine Fig4)
Venlafaxine Hydrochloride 37.5 mg extended-release capsules label from Proficient Rx LP. The label indicates 30 capsules in the package and provides detailed description of the capsule appearance, including color and markings. It includes manufacturer information for Aurobindo Pharma Limited, storage instructions, and multiple replicates of product details including the NDC 71205-408-30.*
FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical Structure (Venlafaxine Str)
Chemical structure of venlafaxine hydrochloride showing its molecular framework with labeled elements and bonds including a cyclohexanol and dimethylamino group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.